Helicobacter pylori eradication to prevent cardio-cerebrovascular disease: Are current data useful for clinical practice?

Int J Cardiol. 2017 Apr 15:233:92. doi: 10.1016/j.ijcard.2016.12.152. Epub 2016 Dec 23.

Authors

Affiliations

¹ Department of Medicine, Second Medical Clinic, Aristotle University of Thessaloniki, Ippokration Hospital, Thessaloniki, Greece. Electronic address: jannis@auth.gr.
² Department of Medicine, Second Medical Clinic, Aristotle University of Thessaloniki, Ippokration Hospital, Thessaloniki, Greece.

PMID: 28043671
DOI: 10.1016/j.ijcard.2016.12.152

No abstract available

Keywords: Cardiovascular disease; Eradication therapy; Fibrinogen; Helicobacter pylori; Metabolic syndrome.

Publication types

Letter
Comment

MeSH terms

Anti-Bacterial Agents
Drug Therapy, Combination
Helicobacter Infections*
Helicobacter pylori*
Humans

Substances

Anti-Bacterial Agents